{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:11:07Z","timestamp":1788563467048,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.radonc.2023.110069","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T12:39:24Z","timestamp":1703162364000},"page":"110069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Quality assurance of radiation therapy after breast-conserving surgery among patients in the BOOG 2013-08 trial"],"prefix":"10.1016","volume":"191","author":[{"given":"V.M.","family":"Wintraecken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.J.","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.","family":"van Roozendaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.J.","family":"van Kuijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.G.","family":"Vane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"van Dalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"van der Hage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.J.A.","family":"Strobbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"Linn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.B.I.","family":"Lobbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.P","family":"Poortmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.C.G.","family":"Tjan-Heijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.K.B.T.","family":"van de Vijver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.H.","family":"Westenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.W.","family":"de Wilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Smidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.110069_b0005","unstructured":"Nationaal Borstkanker Overleg Nederland. Borstkanker. Landelijke richtlijn. 2020."},{"key":"10.1016\/j.radonc.2023.110069_b0010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.radonc.2023.110069_b0015","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.radonc.2023.110069_b0020","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ijrobp.2020.04.042","article-title":"Central review of radiation therapy planning among patients with breast-conserving surgery: results from a quality assurance process integrated into the INSEMA trial","volume":"107","author":"Hildebrandt","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.radonc.2023.110069_b0025","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.breast.2012.06.013","article-title":"Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND)","volume":"21","author":"Gentilini","year":"2012","journal-title":"Breast"},{"key":"10.1016\/j.radonc.2023.110069_b0030","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s12885-017-3443-x","article-title":"Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013\u201308)","volume":"17","author":"van Roozendaal","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2023.110069_b0035","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1200\/JCO.2014.56.5838","article-title":"Radiation field design in the ACOSOG Z0011 (Alliance) Trial","volume":"32","author":"Jagsi","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.110069_b0040","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1245\/s10434-015-4413-7","article-title":"Three-dimensional breast radiotherapy and the elective radiation dose at the sentinel lymph node site in breast cancer","volume":"22","author":"van Roozendaal","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2023.110069_b0045","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/bjs.7360","article-title":"Systematic review of the effect of external beam radiation therapy to the breast on axillary recurrence after negative sentinel lymph node biopsy","volume":"98","author":"van Wely","year":"2011","journal-title":"Br J Surg"},{"key":"10.1016\/j.radonc.2023.110069_b0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.radonc.2016.12.021","article-title":"Ipsilateral axillary recurrence after breast conservative surgery: The protective effect of whole breast radiotherapy","volume":"122","author":"Gentilini","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110069_b0055","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.110069_b0060","doi-asserted-by":"crossref","unstructured":"Vrieling C, van Werkhoven E, Maingon P, Poortmans P, Weltens C, Fourquet A, Schinagl D, Oei B, Rodenhuis CC, Horiot JC, Struikmans H, Van Limbergen E, Kirova Y, Elkhuizen P, Bongartz R, Miralbell R, Morgan DA, Dubois JB, Remouchamps V, Mirimanoff RO, Hart G, Collette S, Collette L, Bartelink H. European Organisation for Research and Treatment of Cancer, Radiation Oncology and Breast Cancer Groups. Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial. JAMA Oncol. 2017 Jan 1;3:42-48. doi: 10.1001\/jamaoncol.2016.3031. PMID: 27607734.","DOI":"10.1001\/jamaoncol.2016.3031"},{"key":"10.1016\/j.radonc.2023.110069_b0065","article-title":"The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus","volume":"14","author":"Kaidar-Person","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.radonc.2023.110069_b0070","doi-asserted-by":"crossref","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C. (Eds.). (2017).TNM classification of malignant tumours. 8th edn. Oxford, UK: Wiley Blackwell, John Wiley & Sons.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"10.1016\/j.radonc.2023.110069_b0075","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.radonc.2011.12.021","article-title":"Reducing interobserver variation of boost-CTV delineation in breast conserving radiation therapy using a pre-operative CT and delineation guidelines","volume":"103","author":"Boersma","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110069_b0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2014.11.030","article-title":"ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer","volume":"114","author":"Offersen","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.110069_b0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijrobp.2009.10.058","article-title":"Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer","volume":"79","author":"Feng","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.110069_b0090","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/annonc\/mdt151","article-title":"The standard tangential fields used for breast irradiation do not allow optimal coverage and dose distribution in axillary levels I-II and the sentinel node area","volume":"24","author":"Belkacemi","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2023.110069_b0095","doi-asserted-by":"crossref","unstructured":"Gentilini OD, Botteri E, Sangalli C, Galimberti V, Porpiglia M, Agresti R, Luini A, Viale G, Cassano E, Peradze N, Toesca A, Massari G, Sacchini V, Munzone E, Leonardi MC, Cattadori F, Di Micco R, Esposito E, Sgarella A, Cattaneo S, Busani M, Dessena M, Bianchi A, Cretella E, Ripoll Orts F, Mueller M, Tinterri C, Chahuan Manzur BJ, Benedetto C, Veronesi P; SOUND Trial Group. Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial. JAMA Oncol. 2023 Sep 21:e233759. doi: 10.1001\/jamaoncol.2023.3759. Epub ahead of print. PMID: 37733364; PMCID: PMC10514873.","DOI":"10.1001\/jamaoncol.2023.3759"},{"key":"10.1016\/j.radonc.2023.110069_b0100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10549-013-2822-5","article-title":"The impact of the pathological lymph node status on adjuvant systemic treatment recommendations in clinically node negative breast cancer patients","volume":"143","author":"van Roozendaal","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.radonc.2023.110069_b0105","doi-asserted-by":"crossref","unstructured":"de Boniface J, Ahlgren J, Andersson Y, Bergkvist L, Frisell J, Lundstedt D, Olofsson Bagge R, Ryd\u00e9n L, Sund M; SENOMAC Trialists\u2019 Group. The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer. Breast Cancer Res Treat. 2020 Feb;180:167-176. doi: 10.1007\/s10549-020-05537-1. Epub 2020 Jan 27. PMID: 31989379; PMCID: PMC7031168.","DOI":"10.1007\/s10549-020-05537-1"},{"key":"10.1016\/j.radonc.2023.110069_b0110","doi-asserted-by":"crossref","unstructured":"Murray Brunt A, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, Bloomfield DJ, Chan C, Churn M, Cleator S, Coles CE, Goodman A, Harnett A, Hopwood P, Kirby AM, Kirwan CC, Morris C, Nabi Z, Sawyer E, Somaiah N, Stones L, Syndikus I, Bliss JM, Yarnold JR; FAST-Forward Trial Management Group. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020 May 23;395:1613-1626. doi: 10.1016\/S0140-6736(20)30932-6. Epub 2020 Apr 28. PMID: 32580883; PMCID: PMC7262592.","DOI":"10.1016\/S0140-6736(20)30932-6"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023093763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023093763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:27:52Z","timestamp":1759123672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023093763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":22,"alternative-id":["S0167814023093763"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.110069","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality assurance of radiation therapy after breast-conserving surgery among patients in the BOOG 2013-08 trial","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.110069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110069"}}